Xoma Corp. Company Profile (NASDAQ:XOMA)

Analyst Ratings

Consensus Ratings for Xoma Corp. (NASDAQ:XOMA) (?)
Ratings Breakdown: 1 Sell Rating(s), 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.08 (251.64% upside)

Analysts' Ratings History for Xoma Corp. (NASDAQ:XOMA)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2016Piper Jaffray Cos.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016Royal Bank Of CanadaReiterated RatingSector Perform$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016WedbushReiterated RatingOutperform$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Jefferies GroupBoost Price TargetHold$1.00 -> $1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Deutsche Bank AGReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2015Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2015SusquehannaDowngradePositive -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Credit Suisse Group AGReiterated RatingNeutral$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/10/2014Roth CapitalInitiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Xoma Corp. (NASDAQ:XOMA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/4/2016($0.12)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.15)$0.21$4.01 million$48.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.16)($0.18)$3.55 million$2.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.18)($0.20)$4.38 million$2.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.16)($0.19)$4.31 million$2.65 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2015Q414($0.14)($0.12)$10.70 million$4.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314($0.17)($0.17)$7.00 million$5.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.21)($0.17)$5.32 million$5.97 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.17)($0.23)$7.40 million$3.41 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2014Q413($0.19)($0.55)$7.92 million$8.45 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.18)($0.21)$7.87 million$6.31 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.19)($0.21)$9.30 million$7.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.21)($0.39)$11.69 million$7.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Xoma Corp. (NASDAQ:XOMA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.10)($0.10)($0.10)
Q2 20162($0.15)($0.09)($0.12)
Q3 20162($0.15)($0.10)($0.13)
Q4 20162($0.15)($0.12)($0.14)
Q1 20171($0.14)($0.14)($0.14)
Q2 20171($0.15)($0.15)($0.15)
Q3 20171($0.15)($0.15)($0.15)
Q4 20171($0.14)($0.14)($0.14)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Xoma Corp. (NASDAQ:XOMA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Xoma Corp. (NASDAQ:XOMA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/22/2016John VarianCEOSell81,022$0.78$63,197.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Patrick J Md Phd ScannonVPSell14,785$0.78$11,532.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Paul D RubinCMOSell24,194$0.78$18,871.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Patrick J Md Phd ScannonVPSell8,000$1.01$8,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2015Patrick J Md Phd ScannonVPSell8,000$1.37$10,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2015Patrick J Md Phd ScannonVPSell8,000$1.35$10,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015Patrick J Md Phd ScannonVPSell8,000$1.04$8,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2015Bros. Advisors Lp BakerInsiderSell11,000,000$1.09$11,990,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015John VarianCEOSell10,000$4.49$44,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Paul D RubinCMOSell5,000$4.60$23,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2015Paul D RubinCMOSell33,400$4.55$151,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015John VarianCEOSell10,000$3.64$36,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015John VarianCEOSell10,000$3.86$38,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Paul D RubinCMOSell32,742$3.94$129,003.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015John VarianCEOSell10,000$3.72$37,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Patrick J Md Phd ScannonVPSell5,000$3.52$17,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2015John VarianCEOSell10,000$3.46$34,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2015Bros. Advisors Lp BakerDirectorSell2,215,400$3.81$8,440,674.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Patrick J Md Phd ScannonVPSell5,000$3.55$17,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2014Bros. Advisors Lp BakerDirectorSell744,000$3.67$2,730,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2014Bros. Advisors Lp BakerDirectorSell1,605,100$4.26$6,837,726.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Bros. Advisors Lp BakerDirectorSell1,033,800$4.46$4,610,748.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014John VarianCEOSell10,000$4.49$44,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Paul D RubinCMOSell1,600$4.63$7,408.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Bros. Advisors Lp BakerDirectorSell392,353$4.62$1,812,670.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Bros. Advisors Lp BakerDirectorSell2,372,206$4.79$11,362,866.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Patrick J Md Phd ScannonVPSell5,000$5.51$27,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014James R NealVPSell1,678$5.67$9,514.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014James R NealVPSell1,032$5.03$5,190.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014Paul D RubinCMOSell5,000$4.55$22,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Fred KurlandCFOSell8,773$3.89$34,126.97View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014James R NealVPSell4,387$3.89$17,065.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014John VarianCEOSell58,844$3.89$228,903.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Patrick J Md Phd ScannonVPSell5,000$4.33$21,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014Paul D RubinCMOSell5,000$4.57$22,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2014John VarianCEOSell10,000$3.87$38,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Patrick J Md Phd ScannonVPSell5,000$4.09$20,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014John VarianCEOSell10,000$4.56$45,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Paul D RubinCMOSell5,000$4.59$22,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014Paul D RubinCMOSell10,000$4.56$45,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Patrick J Md Phd ScannonVPSell5,000$4.31$21,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Paul D RubinCMOSell26,748$4.34$116,086.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Fred KurlandCFOSell10,401$4.31$44,828.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014John VarianCEOSell64,823$4.30$278,738.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Patrick J Md Phd ScannonVPSell5,871$4.31$25,304.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Patrick J Md Phd ScannonVPSell5,000$3.83$19,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2014John VarianCEOSell10,000$4.03$40,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Patrick J Md Phd ScannonVPSell5,000$4.68$23,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014John VarianCEOSell10,000$4.54$45,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Paul D RubinCMOSell11,580$4.54$52,573.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2014Paul D RubinCMOSell1,785$4.22$7,532.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014John VarianCEOSell10,000$3.55$35,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2014John VarianCEOSell10,000$4.06$40,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Fred KurlandCFOSell5,915$6.32$37,382.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014John VarianCEOSell21,329$6.32$134,799.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Patrick Md Phd ScannonVPSell3,419$6.32$21,608.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Paul RubinCMOSell17,649$6.31$111,365.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Thomas KleinInsiderSell30,965$6.32$195,698.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014John VarianCEOSell10,000$6.03$60,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014John VarianCEOSell10,000$7.55$75,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Paul RubinCMOSell6,000$7.55$45,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2014Paul RubinCMOSell6,000$8.27$49,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2014John VarianCEOSell10,000$8.28$82,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Patrick Md Phd ScannonVPSell20,000$8.00$160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2013Paul RubinCMOSell6,000$5.67$34,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2013John VarianCEOSell10,000$5.44$54,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013Patrick Md Phd ScannonVPSell20,000$6.00$120,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2013Paul RubinCMOSell4,696$4.54$21,319.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2013Paul RubinCMOSell1,304$4.08$5,320.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013John VarianCEOSell64,932$3.95$256,481.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2013John VarianCEOSell10,000$4.60$46,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Paul RubinCMOSell6,000$4.53$27,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013John VarianCEOSell10,000$4.59$45,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Bros. Advisors Lp BakerDirectorBuy2,757,791$3.62$9,983,203.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Paul RubinCMOSell6,000$3.74$22,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013John VarianCEOSell61,647$3.87$238,573.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Fred KurlandCFOSell7,498$3.86$28,942.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Patrick Md Phd ScannonVPSell6,002$3.86$23,167.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Paul RubinCMOSell10,520$3.86$40,607.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2013Paul D RubinCMOSell6,000$4.71$28,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013John VarianCEOSell10,000$4.81$48,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2013Paul D RubinCMOSell1,797$4.16$7,475.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2013Paul D RubinCMOSell6,000$0.54$3,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Fred KurlandCFOSell9,111$2.56$23,324.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012John VarianCEOSell40,587$2.56$103,902.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Patrick J Md Phd ScannonEVPSell8,773$2.56$22,458.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2012Julian BakerDirectorBuy4,722,666$3.00$14,167,998.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Xoma Corp. (NASDAQ:XOMA)
DateHeadline
07/28/16 10:45 AMXOMA Corporation (XOMA) Jumps 5.38% on July 27
07/27/16 07:52 PMXOMA Corporation (XOMA) Jumps 5.38% on July 27 - Equities.com
07/26/16 07:56 PMHC Stocks Momentum: XOMA Corp (NASDAQ:XOMA), Inovio Pharmaceuticals Inc (NASDAQ:INO) - share market updates (press release)
07/25/16 07:34 PMXOMA Corporation (XOMA) Shares are Up 4.89% - Trade Calls
07/25/16 04:37 AMBuy XOMA Corporation For Its Monoclonal Antibodies To Treat Congenital Hyperinsulinism And Refractory Prolactinoma - Seeking Alpha
07/24/16 06:49 PMBuy XOMA Corporation For Its Monoclonal Antibodies To Treat Congenital Hyperinsulinism And Refractory Prolactinoma
07/22/16 07:09 PMXOMA Corporation Therapeutics and Product Pipeline Review H1 2016
07/21/16 07:44 PMXOMA Corporation (XOMA) Jumps 14.93% on July 20 | Equities.com - Equities.com
07/21/16 07:44 PMXOMA Corp (NASDAQ:XOMA) & Gap Inc (NYSE:GPS) Trader's ... - Money News (press release)
07/21/16 07:44 PMWhat's New with Celgene Corporation (NASDAQ:CELG), XOMA Corp (NASDAQ:XOMA)? - Post Registrar
07/21/16 10:13 AMEMA grants orphan drug designation to XOMA 358 to treat congenital hyperinsulinism
07/21/16 10:13 AMXOMA's (XOMA) XOMA 358 Granted EMA Orphan Drug Designation as CHI Treatment
07/21/16 10:12 AMAVXS Making News For The Right Reasons, ONVO Pushing Ahead, XOMA Rises 14%
07/20/16 08:30 PMXOMA Receives Orphan Drug Designation in the European Union for XOMA 358 for Treatment of Congenital Hyperinsulinism
07/20/16 08:30 PMXOMA Corporation (XOMA) Jumps 14.93% on July 20
07/19/16 08:19 AMNotable News Buzz: Alibaba Group Holding Ltd (NYSE:BABA), XOMA Corp (NASDAQ:XOMA) - NYSE Journal (press release)
07/16/16 06:35 PMXOMA Corporation Realized Volatility Hits Extreme Level - CML News
07/16/16 06:35 PMXOMA Corporation (XOMA) Drops 5.4% on July 13 - Equities.com
07/08/16 07:17 PMBroker Outlook For XOMA Corporation (XOMA) - Fiscal Standard
07/07/16 07:27 PMXOMA Corporation (XOMA) : Analyst Rating Update - TheFounders Daily
07/05/16 06:57 PMHC Stocks Growth: Keryx Biopharmaceuticals (NASDAQ:KERX), XOMA Corp (NASDAQ:XOMA) - share market updates (press release)
07/05/16 06:57 PMWhy Investors Love These Biotech's Stocks? - XOMA Corp., Navidea Biopharma, Radius Health, and Cara Therapeutics - PR Newswire (press release)
07/05/16 01:31 PMXOMA to Present at the Cantor Fitzgerald Healthcare Conference - [at noodls] - July 5, 2016 BERKELEY, Calif., July 05, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that Dr. Paul Rubin, ...
07/03/16 04:37 AMXoma Corporation (NASDAQ:XOMA) Shorted Shares Decreased By 1.69% - Press Telegraph
07/02/16 06:44 PMXOMA Corporation (XOMA) Drops 11.1% on June 30 - Equities.com
07/02/16 09:53 AMXOMA Corporation (XOMA) Drops 11.1% on June 30
07/01/16 10:03 AMShort Term Price Target on XOMA Corporation (XOMA) - Trade Calls
06/30/16 07:35 PMMovers of most recent trading session: TESARO Inc (NASDAQ:TSRO), XOMA Corp (NASDAQ:XOMA), Exeter Resource ... - iStreetWire
06/30/16 07:35 PMXOMA Corp (XOMA) Stock Gains Big: Here's Why! - CNA Finance (press release)
06/30/16 10:01 AMXOMA Corp (XOMA) Stock Gains Big: Here’s Why!
06/29/16 07:17 PMAnalysts Observing Trading Stocks: Allergan plc. (NYSE:AGN) , XOMA Corporation (NASDAQ:XOMA) - Street Updates
06/29/16 10:02 AMAnalyst Rating Update on XOMA Corporation (XOMA) - Trade Calls
06/29/16 10:02 AMXOMA Corporation (XOMA) Hits New 52-week Low During June 27 Session - Equities.com
06/29/16 10:02 AMCompany Update (NASDAQ:XOMA): XOMA Corp Initiates Phase 2 Proof-of-Concept Study of XOMA 213 - Smarter Analyst
06/28/16 07:20 PMBRIEF-Xoma initiates Phase 2 proof-of-concept study of Xoma 213
06/28/16 07:20 PMXOMA Corporation (XOMA) Hits New 52-week Low During June 27 Session
06/28/16 08:11 AMXOMA Initiates Phase 2 Proof-of-Concept Study of XOMA 213 - [at noodls] - June 28, 2016 BERKELEY, Calif., June 28, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it has initiated its ...
06/28/16 08:05 AM9:05 am XOMA initiates its Phase 2 proof-of-concept study for XOMA 213 -
06/27/16 07:06 PMXOMA Corporation June 15th Short Interest Update - TheFounders Daily
06/27/16 07:06 PMAnalyst's Overview of Two Stocks: MannKind Corporation (NASDAQ:MNKD) , XOMA Corporation (NASDAQ:XOMA) - Street Updates
06/27/16 07:06 PMHC Stocks Overview: XOMA Corp (NASDAQ:XOMA), Biostar Pharmaceuticals Inc (NASDAQ:BSPM) - share market updates (press release)
06/26/16 04:34 AMXoma Corporation (NASDAQ:XOMA) Sellers Covered 4.34% of Their Shorts - Press Telegraph
06/24/16 07:21 PMPrice Target Update on XOMA Corporation (NASDAQ:XOMA) - Trade Calls
06/23/16 08:11 PMStrong Sell Calls Recommendations For XOMA Corporation (NASDAQ:XOMA) At 0 - Investor Newswire
06/23/16 09:53 AMXOMA Corporation (NASDAQ:XOMA) Analyst Rating Consensus - TheFounders Daily
06/20/16 02:29 PMETF’s with exposure to XOMA Corp. : June 20, 2016 -
06/20/16 08:42 AMEarnings Surprise in Focus: XOMA Corporation (NASDAQ:XOMA) - Investor Newswire
06/18/16 04:40 AMXOMA Corporation (XOMA) Hits New 52-week Low During June 16 Session - Equities.com
06/16/16 07:33 PMXOMA Corporation (XOMA) is Trading Lower on Unusual Volume for June 14 - Equities.com
06/16/16 07:33 PMXOMA Corporation (XOMA) Hits New 52-week Low During June 15 Session - Equities.com

Social

About Xoma Corp.

Xoma Corp. logoXOMA Corporation is engaged in the discovery and development of antibody-based therapeutics. The Company's lead product candidate, gevokizumab, is a potent, humanized allosteric-modulating monoclonal antibody that binds to the inflammatory cytokine interleukin-1 beta (IL-1 beta). The Company has initiated three pivotal clinical trials evaluating gevokizumab for the treatment of non-infectious intermediate, posterior or pan-uveitis (NIU) and Behcet's disease uveitis. The Company also has a gevokizumab Proof-of-Concept (POC) development program to identify other illness for late-stage development. These studies are known as the EYEGUARD program, which includes EYEGUARD-A (patients with active NIU), EYEGUARD-B (patients with Behcet's disease uveitis outside of the United States), and EYEGUARD-C (patients with a history of NIU controlled with systemic treatment).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: XOMA
  • CUSIP: 98419J10
Key Metrics:
  • Previous Close: $0.59
  • 50 Day Moving Average: $0.5626
  • 200 Day Moving Average: $0.7573
  • P/E Ratio: N/A
  • P/E Growth: -0.0700
  • Market Cap: $70.07M
  • Beta: 2.58
  • Current Year EPS Consensus Estimate: $-0.45 EPS
  • Next Year EPS Consensus Estimate: $-0.5 EPS
Additional Links:
Xoma Corp. (NASDAQ:XOMA) Chart for Thursday, July, 28, 2016